MyFinsight
Home
Blog
About
Contact
Download
Download image
Realized gain on sale of
digital assets
$4,197,394
Unrealized gain from
changes in fair value of...
$1,812,348
Interest income
$107,595
Change in fv of
derivative
-$55,146
Change in fv of warrant
liability
-$22,377
Trading gains, net
$97
Net loss
-$6,001,137
Total other income
(expense)
$5,911,425
Interest expense
$283,011
Foreign currency
gains/(losses), net
-$521
Loss from operations
-$11,912,562
Total operating
expenses
$11,912,562
General and
administrative expenses
$10,279,981
Research and development
expenses
$1,632,581
Back
Back
Income Statement
source: myfinsight.com
Apimeds Pharmaceuticals US, Inc. (APUS)
Apimeds Pharmaceuticals US, Inc. (APUS)